The Beauty Health Company - SKIN Enterprise Value to EBITDA Ratio
The Beauty Health (SKIN) leads the hardware cosmetology sector, utilizing a recurring sales model for its systems' consumables. This EV/EBITDA price chart currently stands at 9.13. The business leverages the global beauty market, supplying unique skin cleansing technologies to hotels and clinics. High efficiency is achieved through automated equipment assembly lines, which eliminates any production disruptions.
SKIN (Beauty Health): analytical breakdowns and indicator data
- market price and analyst price targets:
- issuer market value details:
- business book valuation details:
- debt obligations and liquidity statistics:
Total Debt to Capital The Beauty Health|SKIN - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio The Beauty Health|SKIN - Aggregate Debt Obligations|Debts to Book Capitalization The Beauty Health Company|SKIN - Company Long-Term Debt|Company Short-Term Debts BeautyHealth|Quick Ratio beautyhealth.com
- net income and valuation multiples indicators:
SKIN - Net Profit|Future Profit The Beauty Health|SKIN - P/E Multiple|Projected Price to Earnings BeautyHealth|SKIN - Company Value to Earnings Growth Ratio|Enterprise Value to EBITDA Ratio The Beauty Health Company|SKIN - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months BeautyHealth|SKIN - Earnings per share for the trailing year|Quarterly EPS earnings growth beautyhealth.com|SKIN - Earnings per share increase in current year|Earnings growth forecast for next year The Beauty Health
- issuer revenue and sales details:
Summary company analysis:beautyhealth.com SKIN
Investments in talent and the development of the HydraFacial brand require significant capital expenditures and debt load management for The Beauty Health (SKIN). The EV/EBITDA multiple compares the total enterprise value, including all liabilities, to operating profit before interest, taxes, depreciation, and amortization. This metric reveals hidden risks of asset stagnation, where low volatility masks a loss of competitiveness. By analyzing the EV/EBITDA trajectory of The Beauty Health (SKIN), an investor determines the real value of the production base relative to current cash flow.
Who The Beauty Health competes with
HCA Healthcare - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio THC (Tenet Healthcare Corporation)|Fresenius Medical Care - EV/EBITDA Multiple|Solventum Corp - Enterprise Value to Operating Income Before Depreciation Ratio|Encompass Health (EHC) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation UHS|Enterprise Value to EBITDA Ratio DVA|EV/EBITDA Multiple RadNet, Inc.|Enterprise Value to EBITDA Ratio OPCH (Option Care Health)|SGRY (Surgery Partners) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Premier Health PINC|America's Best Contacts & Eyeglasses (EYE) - Company Value to EBITDA|PGNY: Enterprise Value to EBITDA Ratio|ARDT (Ardent Health Partners) - Enterprise Value to Operating Income Before Depreciation|SEM (Select Medical Holdings) - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation ASTH|Enterprise Value to EBITDA Ratio MD|USPH: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization The Pennant Group (PNTG)|ORGO - Company Value to EBITDA|EV/EBITDA Multiple NUTX (nutexhealth.com)|EV/EBITDA Multiple Auna S.A. AUNA|SBC - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Evolus, Inc. (EOLS) - Enterprise Value to EBITDA Ratio|CYH: EV/EBITDA Multiple|MDWD (MediWound Ltd.) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|BTMD (biote Corp) - EV/EBITDA Multiple|Company Value to EBITDA The Joint Corp JYNT|EV/EBITDA Multiple DCGO|Enterprise Value to EBITDA Ratio p3hp.org PIII|Gain Therapeutics, Inc. - Enterprise Value to EBITDA Ratio|EUDA: Enterprise Value to Operating Income Before Depreciation|baselmedical.com - EV/EBITDA Multiple|Company Value to EBITDA collplant.com|Cuprina Holdings Limited (CUPR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CCM - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization American Shared Hospital Services Inc|Enterprise Value to Operating Income Before Depreciation MRM (MEDIROM Healthcare Group)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Avalon GloboCare Corp. (ALBT)|Enterprise Value to EBITDA Ratio DIH Holding US Inc. DHAI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization carmellcosmetics.com XAGE|NIVF - Enterprise Value to EBITDA Ratio|ATIP: Enterprise Value to EBITDA Ratio|CMAX - EV/EBITDA Multiple|KDLY: EV/EBITDA Multiple|Company Value to EBITDA ModivCare (MODV)|NVOS (Novo Integrated Sciences Corp) - EV/EBITDA Multiple|sunlinkhealth.com (SSY) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio BACK (IMAC Regeneration Centers)
